Login
FORUM MARKETS Inc logo

FORUM MARKETS Inc

forum-markets.com

What Do They Do?

Provides Ethereum staking capacity to validators and protocols, and builds blockchain infrastructure to turn consumer loans, equipment finance and other cash-flowing assets into tokenized investment products for investors.

How Do They Make Money?

Liquid-staking platforms receive delegated ETH capacity, and the Company earns daily protocol rewards and incentive tokens; native staking also generates daily rewards through validator operators.

revenue
SegmentShareRevenue
Native staking revenue
Recurring
7.0%
Liquid staking revenue
Recurring

91%
Reward revenue
Recurring
2.2%

Who Are Their Customers?

Validator operators and liquid-staking platforms receive the Company’s staking capacity; the Company stakes through agreements with custodians and asset managers. Planned tokenized products are expected to be distributed mainly through Liquidity.io.

Do Revenues Turn Into Profits?

No. It lost $450.5M in FY2025.

Operating income, FY2025
−3566% of revenue
▼ −5183% (Loss) vs FY2024 (−$4.4M)
Net income, FY2025
−6881% of revenue
▼ −3077% (Loss) vs FY2024 (−$14.2M)
Free cash flow, FY2025
−4129% of revenue
▼ −22985% (Loss) vs FY2024 (−$1.2M)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −51%
vs $4.1M in Q3 FY2025
Net income
▲ Turned profitable
vs −$216.7M in Q3 FY2025
  • Nov 12, 2026 Cut 2026 revenue guidance and maintained 2027 guidance Now expects 2026 revenue of $8 million to $9 million, down from $18 million to $22 million; maintained 2027 guidance of $125 million to $175 million.
  • Oct 26, 2026 Signed a long-term AI compute services deal with Fireworks Fireworks reserved Nvidia B300 GPU capacity in Dallas under a 36-month agreement valued at approximately $94.4 million, with a prepayment deposit.
  • Oct 2, 2026 Created an AI infrastructure joint venture with Edge Node Forum holds 51% of the venture, which plans to operate compute sites at existing powered data facilities and tower locations.

From drug development to tokenized assets The older report described a clinical-stage biotechnology business developing therapeutics for chronic pain, inflammation and fibrosis. The latest report focuses on blockchain-based infrastructure for originating, financing and distributing tokenized income-generating assets.

Who Do They Compete With?

Competes with BlackRock, KKR, Apollo, and Hamilton Lane

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support